AngioDynamics, Inc.
US ˙ NasdaqGS ˙ US03475V1017

SecurityANGO / AngioDynamics, Inc.
InstitutionSystematic Financial Management Lp
Latest Disclosed Ownership2,508,295 shares
Ownership 6.10%
Systematic Financial Management Lp ownership in ANGO / AngioDynamics, Inc.

2026-02-10 - Systematic Financial Management Lp has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,508,295 shares of AngioDynamics, Inc. (US:ANGO). This represents 6.1 percent ownership of the company. In their previous filing dated 2025-02-13 , Systematic Financial Management Lp had reported owning 2,521,066 shares, indicating a decrease of -0.51 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2026-02-10 2026-02-10 13G 2,521,066 2,508,295 -0.51 6.10 -1.61
2025-02-13 2025-02-13 13G/A 2,521,066 6.20
2025-02-13 2025-02-13 13G 2,521,066 6.20

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F AngioDynamics COM 03475V101 2,453,701 -51,163 -2.04 27,899 -13.26 0.5260
2026-02-09 2025-12-31 13F AngioDynamics COM 03475V101 2,504,864 -65,642 -2.55 32,162 12.02 0.7581
2025-11-13 2025-09-30 13F AngioDynamics COM 03475V101 2,570,506 60,600 2.41 28,713 15.32 0.6981
2025-08-13 2025-06-30 13F AngioDynamics COM 03475V101 2,509,906 12,617 0.51 24,898 6.18 0.6643
2025-05-14 2025-03-31 13F AngioDynamics COM 03475V101 2,497,289 -23,776 -0.94 23,450 1.55 0.6680
2025-02-14 2024-12-31 13F AngioDynamics COM 03475V101 2,521,065 110,719 4.59 23,093 23.14 0.5877
2024-11-14 2024-09-30 13F AngioDynamics COM 03475V101 2,410,346 300,785 14.26 18,752 46.94 0.4776
2024-08-16 2024-06-30 13F AngioDynamics COM 03475V101 2,109,561 162,972 8.37 12,763 11.69 0.3877
2024-05-15 2024-03-31 13F AngioDynamics COM 03475V101 1,946,589 14,435 0.75 11,426 -24.57 0.3189
2024-02-14 2023-12-31 13F AngioDynamics COM 03475V101 1,932,154 31,374 1.65 15,148 9.03 0.4494
2023-11-14 2023-09-30 13F AngioDynamics COM 03475V101 1,900,780 476,449 33.45 13,895 -6.47 0.4474
2023-08-14 2023-06-30 13F AngioDynamics COM 03475V101 1,424,331 19,242 1.37 14,856 2.25 0.4688
2023-05-12 2023-03-31 13F AngioDynamics COM 03475V101 1,405,089 132,928 10.45 14,529 -17.06 0.4751
2023-02-15 2022-12-31 13F AngioDynamics COM 03475V101 1,272,161 216,862 20.55 17,518 -18.87 0.5739
2022-11-14 2022-09-30 13F AngioDynamics COM 03475V101 1,055,299 905 0.09 21,591 5.82 0.7876
2022-08-15 2022-06-30 13F AngioDynamics COM 03475V101 1,054,394 41,823 4.13 20,403 -6.46 0.7086
2022-05-11 2022-03-31 13F AngioDynamics COM 03475V101 1,012,571 16,404 1.65 21,811 -20.61 0.6806
2022-02-14 2021-12-31 13F AngioDynamics COM 03475V101 996,167 -79,458 -7.39 27,474 -1.53 0.8146
2021-11-12 2021-09-30 13F AngioDynamics COM 03475V101 1,075,625 -2,830 -0.26 27,902 -4.63 0.8641
2021-08-12 2021-06-30 13F AngioDynamics COM 03475V101 1,078,455 128,517 13.53 29,258 31.62 0.8846
2021-05-10 2021-03-31 13F AngioDynamics COM 03475V101 949,938 -27,816 -2.84 22,229 48.30 0.8136
2021-02-12 2020-12-31 13F AngioDynamics COM 03475V101 977,754 -13,636 -1.38 14,989 25.37 0.6578
2020-11-12 2020-09-30 13F AngioDynamics COM 03475V101 991,390 26,437 2.74 11,956 21.83 0.6539
2020-08-13 2020-06-30 13F Angiodynamics COM 03475V101 964,953 271,121 39.08 9,814 35.61 0.5101
2020-05-12 2020-03-31 13F Angiodynamics COM 03475V101 693,832 186,239 36.69 7,237 -10.95 0.4443
2020-02-14 2019-12-31 13F Angiodynamics COM 03475V101 507,593 97,075 23.65 8,127 7.47 0.3178
2019-11-06 2019-09-30 13F Angiodynamics COM 03475V101 410,518 29,896 7.85 7,562 0.91 0.3389
2019-07-26 2019-06-30 13F Angiodynamics COM 03475V101 380,622 325,172 586.42 7,494 491.01 0.2914
2019-05-03 2019-03-31 13F Angiodynamics COM 03475V101 55,450 2,655 5.03 1,268 19.29 0.0434
2019-02-13 2018-12-31 13F Angiodynamics COM 03475V101 52,795 -12,440 -19.07 1,063 -25.04 0.0327
2018-11-06 2018-09-30 13F Angiodynamics COM 03475V101 65,235 -16,900 -20.58 1,418 -22.39 0.0342
2018-08-08 2018-06-30 13F Angiodynamics COM 03475V101 82,135 -46,897 -36.35 1,827 -17.92 0.0446
2018-05-09 2018-03-31 13F Angiodynamics COM 03475V101 129,032 -170,275 -56.89 2,226 -55.27 0.0493
2018-02-09 2017-12-31 13F Angiodynamics COM 03475V101 299,307 -2,803 -0.93 4,977 -3.60 0.0994
2017-11-08 2017-09-30 13F Angiodynamics COM 03475V101 302,110 -74,095 -19.70 5,163 -15.33 0.1047
2017-08-10 2017-06-30 13F Angiodynamics COM 03475V101 376,205 -72,456 -16.15 6,098 -21.66 0.1127
2017-05-11 2017-03-31 13F Angiodynamics COM 03475V101 448,661 -337,991 -42.97 7,784 -41.35 0.1378
2017-02-10 2016-12-31 13F Angiodynamics COM 03475V101 786,652 -66,751 -7.82 13,271 -11.34 0.2108
2017-01-26 2016-09-30 13F/A-4 Angiodynamics COM 03475V101 853,403 -17,643 -2.03 14,969 19.60 0.2099
2016-11-14 2016-09-30 13F Angiodynamics COM 03475V101 853,403 14,968
2017-01-25 2016-06-30 13F/A-2 Angiodynamics COM 03475V101 871,046 88,967 11.38 12,516 30.23 0.1706
2016-08-09 2016-06-30 13F Angiodynamics COM 03475V101 871,046 12,516
2016-05-11 2016-03-31 13F Angiodynamics COM 03475V101 782,079 -7,417 -0.94 9,611 0.28 0.1202
2016-02-10 2015-12-31 13F Angiodynamics COM 03475V101 789,496 -62,630 -7.35 9,584 -14.73 0.1047
2015-11-06 2015-09-30 13F Angiodynamics COM 03475V101 852,126 103,982 13.90 11,239 -8.40 0.1193
2015-08-10 2015-06-30 13F Angiodynamics COM 03475V101 748,144 52,769 7.59 12,269 -0.82 0.1050
2015-05-11 2015-03-31 13F Angiodynamics COM 03475V101 695,375 -129,282 -15.68 12,370 -21.09 0.0977
2015-02-10 2014-12-31 13F Angiodynamics COM 03475V101 824,657 -269,835 -24.65 15,676 4.40 0.1158
2014-11-12 2014-09-30 13F Angiodynamics COM 03475V101 1,094,492 -26,227 -2.34 15,016 -17.95 0.1094
2014-08-11 2014-06-30 13F Angiodynamics COM 03475V101 1,120,719 103,910 10.22 18,301 14.28 0.1249
2014-08-11 2014-03-31 13F/A-1 Angiodynamics COM 03475V101 1,016,809 -8,648 -0.84 16,014 -8.99 0.1100
2014-05-15 2014-03-31 13F Angiodynamics COM 03475V101 1,016,809 16,014
2014-08-11 2013-12-31 13F/A-2 Angiodynamics COM 03475V101 1,025,457 -96,806 -8.63 17,596 18.79 0.1289
2014-02-14 2013-12-31 13F Angiodynamics COM 03475V101 1,025,457 17,596
2014-08-11 2013-09-30 13F/A-3 Angiodynamics COM 03475V101 1,122,263 297,354 36.05 14,813 59.21 0.1173
2013-11-12 2013-09-30 13F Angiodynamics COM 03475V101 1,122,263 14,813
2013-08-06 2013-06-30 13F Angiodynamics COM 03475V101 824,909 824,909 9,304 0.0797
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.